Our new dedicated Metoject PEN® website has been designed to inform and aid HCPs and patients with important information and resources about the Metoject PEN®.  

What is the Metoject PEN®?

A prefilled autoinjector containing methotrexate (MTX) solution at a concentration of 50mg/ml, indicated for the treatment of:

  • Severe recalcitrant disabling psoriasis
  • Severe psoriatic arthritis in adult patients

Once prescribed the Metoject PEN®, a patient can be referred for our Metoject at home care service, a unique and complimentary patient centric service, providing:

  • 1:1 nurse training in the patient’s home 
  • sharps waste bin delivered directly to patient’s home

Full details and patient referral information can be found by following this link:

Contact Details:

With a heritage of care giving dating back to 1829 we have the track record to support our claims!

Date or preparation: April 2021
Code: IE2021/012/00